EP Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.9K Buy
16,799
+501
+3% +$1.18K ﹤0.01% 1485
2025
Q4
$44.2K Buy
+16,298
New +$53.5K ﹤0.01% 1465
2025
Q2
$76.6K Sell
15,382
-338
-2% -$1.47K ﹤0.01% 1398
2025
Q1
$69.3K Buy
+15,720
New +$73.8K ﹤0.01% 1265
2024
Q4
Sell
-10,547
Closed -$73.2K 1272
2024
Q3
$73.2K Buy
+10,547
New +$82.8K ﹤0.01% 1153

Other funds holding GDRX

EP Wealth Advisors's GDRX Position: Q1 2026 in Review

EP Wealth Advisors increased its GoodRx Holdings (GDRX) stake by 3.1% in Q1 2026, buying an estimated $1.18K and bringing the position to 16,799 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

EP Wealth Advisors first reported a position in GDRX in Q3 2024 and has held it in 5 quarters since. The position peaked at $76.6K in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • EP Wealth Advisors held 16,799 shares of GoodRx Holdings worth $32.9K as of Q1 2026.
  • EP Wealth Advisors bought 501 GoodRx Holdings shares in Q1 2026, an estimated $1.18K.
  • GoodRx Holdings made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #1485 holding.
  • EP Wealth Advisors first reported a position in GoodRx Holdings in Q3 2024 and has held it in 5 quarters since.
  • EP Wealth Advisors's GoodRx Holdings position peaked at $76.6K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.